AGENT FOR REDUCING RISK AND RELIEVING SYMPTOMS OF BETA-CORONAVIRUS INFECTION Russian patent published in 2021 - IPC A61K9/08 A61K9/72 A61K31/7052 A61K38/06 A61P31/14 

FIELD: medicine.

SUBSTANCE: group of inventions relates to the field of medicine, namely to infections diseases, and is intended for the prevention and treatment of infections caused by beta-coronaviruses. Proposed is an agent for reducing the risk of occurrence and/or relieving the symptoms of beta-coronavirus infection in form of an inhalation solution includes glutathione or a composition of glutathione disulfide and glutathione disulfide S-oxide, inosine as a complex active ingredient, potassium chloride and water for injection. Components are used in labeled amount. Also proposed is the use of the said agent for reducing the risk of occurrence and/or relieving symptoms of beta-coronavirus infection. The agent is sprayed with a nebulizer providing a particle size of 4-5 microns with a volume velocity of compressed air of 0.25 ml/min for 3-12 minutes per session, 10-14 days for 2-4 inhalations per day and 4-12-hour periods between sessions.

EFFECT: use of the group of invention allows increasing effectiveness of medicamentous prevention of beta-coronavirus infection and/or relieving its symptoms in persons who are at high risk of contracting this infection.

3 cl, 1 tbl, 4 ex